BlueGradientOnly.png
PrimaryWithTaglineWhitePadded.png

CASE STUDY

CHRONIC DISSECTION PATIENT RECEIVES GROUNDBREAKING MINIMALLY INVASIVE TREATMENT IN TRIOMPHE CLINICAL STUDY

CHRONIC DISSECTION PATIENT RECEIVES GROUNDBREAKING MINIMALLY INVASIVE TREATMENT IN TRIOMPHE CLINICAL STUDY

FIGURE A: Pre-op three-dimensional reconstruction shows anatomy with true lumen. FIGURE B: Intra-operative angio, post implant. FIGURE C: Post-op three dimensional reconstruction shows NEXUS position at 30 days

CHRONIC DISSECTION PATIENT RECEIVES GROUNDBREAKING MINIMALLY INVASIVE TREATMENT IN TRIOMPHE CLINICAL STUDY
Artboard 1.png

PATIENT INFORMATION

A 56-year old male with history of coronary artery disease, hypertension, hyperlipidemia, previous MI, and previous tobacco use, underwent repair of a Type A aortic dissection with a 30mm Valsalva gelweave graft in 2019.

Artboard 5.png

REASON TO TREAT

Follow-up CT scans of the arch note that the aortic arch had grown significantly over the past year and a half. The aortic arch was measuring 5.2cm in its greatest dimension. Due to the rapid enlargement and the patient’s young age, the patient was scheduled for treatment with NEXUS as part of the TRIOMPHE Study.

Artboard 4.png

DEBRANCHING

A right common carotid artery, left common carotid artery, left subclavian bypass was surgically performed two days before the index procedure.

Artboard 3.png

NEXUS IMPLANTATION

NEXUS, with an optional distal extension, was successfully implanted during an uneventful procedure with an optimal outcome, at total device time of 89 minutes.

Artboard 2.png

PROCEDURAL OUTCOME

Six month follow-up CT shows a stable position of NEXUS and no endoleak identified.

Artboard 6.png

PHYSICIAN'S PUBLISHED COMMENTS

“Aortic arch repair is customarily one of the most technically difficult areas to repair. As with most aortic arch procedures, the patient involved had a previous open aortic arch repair and was not suitable for another large invasive procedure. We are pleased that The Christ Hospital is able to offer an alternative minimally invasive solution to patients to avoid large open repairs of their aortic arch.”


Geoffrey Answini, MD, FACS, Director of the Cardiothoracic Surgery Division at The Christ Hospital

BlueGradientOnly.png

The Christ Hospital

Cardiothoracic Surgery Division

Cincinnati, Ohio

Ellipse 4.png

Geoffrey A. Answini, MD,
FACS

Ellipse 4.png

Mark Harding, MD, FACS

Ellipse 4.png

Ellipse 4.png

Director of the Cardiwothoracic Surgery Division

Vascular Surgeon

EndospanLogoWhite.png

CAUTION: Investigational Device – Limited by United States law to investigational use. Endospan devices bear the CE marking of conformity.

XXXXXXXXX Rev1.0